This result is counter to what might be expected from a member of the ERBB family—as we can see from the right-shifted EGFR copy number distribution—and suggested that ERBB4 may be acting as a tumor suppressor in gliomas. The gene discussed is EGFR; the disease is central nervous system cancer.